Last Updated On 3/21/2023 8:35:13 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
Company: Science 37 |
Recipient: You |
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Ipsen |
Recipient: You |
Company: Cancer Commons |
Recipient: You |
Company: Foundation Medicine |
Recipient: You |
Company: Genmab/Seagen |
Recipient: You |
|
Speakers' Bureau |
Company: Sirtex |
Recipient: You |
|
Research Funding |
Company: ImmuneSensor Therapeutics |
Recipient: An Immediate Family Member |
Company: Bristol-Myers Squibb |
Recipient: Your Institution |
Company: Tolero Pharmaceuticals |
Recipient: Your Institution |
Company: Delfi Diagnostics |
Recipient: Your Institution |
Company: Merck |
Recipient: Your Institution |
Company: Merck Serono |
Recipient: Your Institution |
Company: AstraZeneca/MedImmune |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|